- Biomedical Sciences
Introduction of the classroom
We study biomedical sciences via molecular and cellular biology.
Followings are recent RESEARCH INTERESTS of faculty members in our department.
1. Prof. In-Kyu Park: Delivery of gene and protein into living organisms
We study to increase the efficiency of delivery of gene and protein into living organisms, which would help to develop effective therapeutic modalities against human diseases.
2. Prof. Hee-Young Shin: Clinical epidemiology and research ethics
Prof. Hee-Young Shin works in the area of clinical epidemiology and research ethics. Dr. Shin is mainly interested in the scientific and ethical conduct of clinical trials. Clinical epidemiology and biostatistics are the basic elements to implement a scientific clinical research. And the ethical considerations are very important in developing an innovative medical treatment. The other areas of interest are geriatric diseases (including dementia) and public health.
3. Prof. Seok-Yong Choi: Fate specification of glial cells
The central nervous system (CNS) consists of neurons and glial cells. Knowledge about fate specification of cells in the CNS is essential to develop therapeutic modalities for CNS diseases, especially neurodegenerative diseases. Whereas fate specification of neuron has been studied extensively, that of glial cells remains unclear. My research group investigates the fate specification of glial cells, especially ependymal cells, in the zebrafish model using genetic and cell biological approaches.
4. Prof. Jihoon Jo
Research in our lab focuses on a wide range of projects from molecular mechanisms of synaptic plasticity which is a strong model for learning and memory and Neurodegenerative disease including Alzheimer’s disease.
5. Prof. Hoon Hyun: Molecular Imaging
The lab focuses on the development of novel contrast agents for tissue- and organ-specific targeting and diagnosis. Of particular interest is “Structure-Inherent Targeting,” where small molecules can be used for targeting, imaging, diagnosis and therapy by specifically visualizing target tissue with high optical properties and by avoiding nonspecific uptake in normal background tissues.
6. Prof. Vinoth Kumar Lakshmanan: Biomedical Sciences
Recent advances in cancer nanomedicine have attracted remarkable attention in medical sectors. Pharmacologic research on nanomedicines including targeted cancer therapy, has increased dramatically in the past 5 years. The success stories of nanomedicines in the clinical field include the fabrication of nanomedicines that show minimum toxicity to healthy cells. Our research laboratory exploring novel strategies for cancer employing nanotherapeutics to improve their safety and efficacy using animal models